[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$faH4OEdvGNzjnqLzR5owKPJjLvTS9kL_1JQa3QhzS7U0":8,"$fc-nAC5VZUgQ1zphAd3QYMBh4Cy5vB-v_-UdY-cFuPx4":55,"$fs5Ddy2B1Xe-KqAjRUEM48wsGtkZL4xYCiU77cyAbhko":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65652,867568,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//Qwz6GyCWTi4XHRajDQhvP0c86fSiOy65.png","李文旭","温州老年病医院","肿瘤科","主治医师",317,0,"胆管恶性肿瘤用药指南：化疗方案与安全细节","","https://ystcdn.venuertc.com/venue/AI/0cf43e9a-54e0-419d-b091-d08af7462aa8.jpg","\u003Ch2 id=\"material_title\" class=\"bile-drug-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">胆管恶性肿瘤用药指南：化疗方案与安全细节\u003C/h2>\n\n\u003Cdiv class=\"bile-drug-section\" style=\"background: linear-gradient(90deg, #f0f4ff 0%, #e6edf7 100%); padding: 24px 20px 12px 20px; margin-bottom:32px;\">\n    \u003Ch3 class=\"bile-drug-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">开篇导读\u003C/h3>\n    \u003Cp class=\"bile-drug-p\">说起来，胆管恶性肿瘤相关化疗药品涉及多种注射剂和口服制剂。常见有环磷酰胺、长春地辛、多柔比星脂质体、利妥昔单抗等，还有辅助用药如地塞米松与昂丹司琼。有不少关键细节需要关注，比如给药方式、不良反应及用药禁忌。本文将详细讲解胆管恶性肿瘤实际化疗常见药品的使用方法、剂型及五大安全注意事项，让大家在实际用药过程中少走弯路，合理规避风险。\u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"bile-drug-section\" style=\"background: linear-gradient(90deg, #f5fff6 0%, #e9f6eb 100%); padding: 22px 18px 12px 18px; margin-bottom:28px;\">\n    \u003Ch3 class=\"bile-drug-h3 bile-drug-emoji\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">💊 主要化疗药品及辅助药介绍\u003C/h3>\n    \u003Cul class=\"bile-drug-list\">\n        \u003Cli>环磷酰胺针剂（注射剂型）：烷化剂，作用机制为干扰DNA复制，使细胞不能正常分裂。\u003C/li>\n        \u003Cli>长春地辛针剂（注射剂型）：影响微管形成，抑制细胞分裂。\u003C/li>\n        \u003Cli>多柔比星脂质体（注射剂型）：插入DNA双链，阻断复制和转录。\u003C/li>\n        \u003Cli>利妥昔单抗（注射剂型）：单克隆抗体，靶向免疫系统相关细胞。\u003C/li>\n        \u003Cli>昂丹司琼注射液（止吐辅助）：5-HT3受体拮抗剂，用于预防化疗相关恶心、呕吐。\u003C/li>\n        \u003Cli>地塞米松（辅药）：糖皮质激素，辅助缓解化疗药不良反应。\u003C/li>\n        \u003Cli>异丙嗪（止吐及镇静）：可缓解不适和过敏反应。\u003C/li>\n        \u003Cli>洛索洛芬钠片（口服非甾体消炎止痛药）：用于缓解疼痛等不适。\u003C/li>\n        \u003Cli>氯化钠、葡萄糖注射液（静脉稀释剂型）：用于药品稀释与输注。\u003C/li>\n    \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"bile-drug-section\" style=\"background: linear-gradient(90deg, #fff7fa 0%, #f5eaf0 100%); padding: 20px 16px 12px 16px; margin-bottom:28px;\">\n    \u003Ch3 class=\"bile-drug-h3 bile-drug-emoji\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🕑 01. 化疗药品的服药时间和正确方法\u003C/h3>\n    \u003Cp class=\"bile-drug-p\">\u003Cstrong>静脉用药细节\u003C/strong>\u003C/p>\n    \u003Cul class=\"bile-drug-list\">\n        \u003Cli>环磷酰胺、长春地辛、多柔比星脂质体、利妥昔单抗多数通过静脉滴注（ivgtt）或静脉注射（iv）完成，需要医生严格把控速度和浓度，绝不可随意加快。（参考：Levine et al., 2021）\u003C/li>\n        \u003Cli>昂丹司琼、异丙嗪可用于静脉或肌肉注射，基本由专科护士完成，不宜自行注射。\u003C/li>\n        \u003Cli>洛索洛芬钠片为口服药，建议餐后服用，可减少胃刺激。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"bile-drug-p\">正确做法：所有针剂类药品绝不建议自行在家注射，需在医院或专业医疗机构治疗。口服药要足量温水送服。\u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"bile-drug-section\" style=\"background: linear-gradient(90deg, #eafafb 0%, #e6f7f5 100%); padding: 18px 16px 12px 16px; margin-bottom:28px;\">\n    \u003Ch3 class=\"bile-drug-h3 bile-drug-emoji\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">💡 02. 剂型选择与使用技巧\u003C/h3>\n    \u003Cul class=\"bile-drug-list\">\n        \u003Cli>针剂类多以安瓿或预充注射器形式提供，使用时需确保液体无沉淀、无变色，严禁使用过期或被污染的制剂。\u003C/li>\n        \u003Cli>多柔比星脂质体属于脂质体包裹剂型，更稳定，降低心脏毒性。输注必须控制速度，如过快易引发心血管不良反应。\u003C/li>\n        \u003Cli>口服洛索洛芬钠片应整片吞服，切勿掰碎或嚼服，否则影响缓释效果。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"bile-drug-p\">需要注意：药剂师配药时应仔细核对药品规格和剂量，经常用到的葡萄糖、氯化钠注射液仅作稀释，不可单独代替药品使用。\u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"bile-drug-section\" style=\"background: linear-gradient(90deg, #fff8e2 0%, #fcf3d6 100%); padding: 22px 18px 12px 18px; margin-bottom:28px;\">\n    \u003Ch3 class=\"bile-drug-h3 bile-drug-emoji\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">📑 03. 药物相互作用详解\u003C/h3>\n    \u003Cul class=\"bile-drug-list\">\n        \u003Cli>环磷酰胺与其他免疫抑制剂（如地塞米松）联用时可能增强抑制免疫效应，应严格监控用量。\u003C/li>\n        \u003Cli>昂丹司琼与其他抗5-HT3药物合用可能增加心律失常风险，建议单用。\u003C/li>\n        \u003Cli>多柔比星类药物不能与酮康唑等CYP3A4抑制剂同服，避免药物浓度升高导致毒性反应。\u003C/li>\n        \u003Cli>利妥昔单抗与免疫刺激药联合时需警惕过度抑制或过度免疫激活。\u003C/li>\n        \u003Cli>洛索洛芬钠片不宜与其他非甾体类消炎药同用，以防加重肾脏负担。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"bile-drug-p\">正确做法：化疗期间如需服用其他药品，一定提前让主诊医生知晓，避免相互作用引起严重副作用。\u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"bile-drug-section\" style=\"background: linear-gradient(90deg, #f9f9ff 0%, #e7eefe 100%); padding: 20px 18px 12px 18px; margin-bottom:28px;\">\n    \u003Ch3 class=\"bile-drug-h3 bile-drug-emoji\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🥼 04. 特殊人群用药调整 🌱\u003C/h3>\n    \u003Cul class=\"bile-drug-list\">\n        \u003Cli>老年患者使用环磷酰胺、多柔比星需减量，因肝肾排泄功能减弱，药物累积风险增加。\u003C/li>\n        \u003Cli>儿童和青少年需要根据体重（mg/kg）精确计算剂量。\u003C/li>\n        \u003Cli>孕妇和哺乳期妇女普遍禁用环磷酰胺、长春地辛、多柔比星脂质体等强细胞毒药物。\u003C/li>\n        \u003Cli>肝肾功能不全者应明确告知医生，以便调整剂量。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"bile-drug-p\">特别提醒：每种药品的剂量决定权在医生，切勿自行增减剂量。\u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"bile-drug-section\" style=\"background: linear-gradient(90deg, #eaf7e4 0%, #dff1f7 100%); padding: 20px 16px 12px 16px; margin-bottom:28px;\">\n    \u003Ch3 class=\"bile-drug-h3 bile-drug-emoji\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">⚠️ 05. 常见不良反应和应对方法\u003C/h3>\n    \u003Cul class=\"bile-drug-list\">\n        \u003Cli>环磷酰胺和多柔比星脂质体：易引起骨髓抑制、脱发、消化道反应，如恶心、白细胞减少。\u003C/li>\n        \u003Cli>长春地辛：常见周围神经病变，麻木感或行动迟缓。\u003C/li>\n        \u003Cli>利妥昔单抗：偶发输液反应（如寒战、发热）。\u003C/li>\n        \u003Cli>昂丹司琼副作用有头痛、便秘。\u003C/li>\n        \u003Cli>少数患者使用洛索洛芬钠片后会出现胃肠不适。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"bile-drug-p\">正确做法：一旦出现明显不良反应，如发热、皮疹或异常乏力，应及时联系医生调整治疗。如出现严重过敏反应（脸部肿胀、呼吸困难等），要立刻就医。\u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"bile-drug-section\" style=\"background: linear-gradient(90deg, #fff8f3 0%, #feebee 100%); padding: 20px 16px 12px 16px; margin-bottom:28px;\">\n    \u003Ch3 class=\"bile-drug-h3 bile-drug-emoji\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🗄 06. 储存条件与药品保存\u003C/h3>\n    \u003Cul class=\"bile-drug-list\">\n        \u003Cli>针剂类化疗药（环磷酰胺、多柔比星脂质体、长春地辛、利妥昔单抗）建议在2-8°C冷藏，避免阳光直射。\u003C/li>\n        \u003Cli>口服洛索洛芬钠片需存放在干燥阴凉处（≤25°C），防止受潮。\u003C/li>\n        \u003Cli>开封后药品务必在说明书规定时间内用完，剩余药品不能继续存放以免失效。\u003C/li>\n        \u003Cli>葡萄糖、氯化钠注射液如有沉淀或浑浊应弃用。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"bile-drug-p\">正确做法：定期检查药品有效期，过期和变质药品需按废弃药标准安全处理，勿随意丢弃。\u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"bile-drug-section\" style=\"background: linear-gradient(90deg, #eff6fb 0%, #e0eaf3 100%); padding: 24px 20px 12px 20px; margin-bottom:32px;\">\n    \u003Ch3 class=\"bile-drug-h3 bile-drug-emoji\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">📝 07. 漏服、过量及应急处理\u003C/h3>\n    \u003Cul class=\"bile-drug-list\">\n        \u003Cli>口服药如洛索洛芬钠片漏服，不建议双重补服，下次按常规剂量服药。\u003C/li>\n        \u003Cli>化疗针剂如错过规定时间建议及时联系医生，不可自行加量或临时补打。\u003C/li>\n        \u003Cli>过量服用环磷酰胺或多柔比星有致命风险，表现为严重骨髓抑制、感染。应立即前往医院。\u003C/li>\n        \u003Cli>出现过量或严重反应时，家属应保留药品外包装，以便医生分析。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"bile-drug-p\">正确做法：一旦怀疑药量异常，千万不要自行处理，及时就医是唯一安全选择。\u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"bile-drug-section\" style=\"background: linear-gradient(90deg, #fffdf3 0%, #f3fbe4 100%); padding: 24px 20px 12px 20px; margin-bottom:32px;\">\n    \u003Ch3 class=\"bile-drug-h3 bile-drug-emoji\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">👨‍⚕️ 实际用药案例分享\u003C/h3>\n    \u003Cul class=\"bile-drug-list\">\n        \u003Cli>临床上，一位60岁男性（170cm/60kg）静脉注射环磷酰胺、长春地辛、多柔比星脂质体联合化疗期间出现白细胞骤降，经调整剂量及补充辅助用药后缓解。\u003C/li>\n        \u003Cli>另有患者静脉滴注利妥昔单抗时发生寒战，经降速处理后解决，无后续严重反应。\u003C/li>\n        \u003Cli>口服洛索洛芬钠片患者出现胃部不适，停药后自行缓解，无需特殊治疗。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"bile-drug-p\">以上案例仅用于说明药品使用过程中的实际问题，重点在于：任何异状都不可掉以轻心。\u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"bile-drug-section\" style=\"background: linear-gradient(90deg, #f6faff 0%, #e9edf8 100%); padding: 30px 22px 18px 22px; margin-bottom:36px;\">\n    \u003Ch3 class=\"bile-drug-h3 bile-drug-emoji\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">⭐ 结语与重点提醒\u003C/h3>\n    \u003Cul class=\"bile-drug-list\">\n        \u003Cli>胆管恶性肿瘤相关化疗药品种类多、用药流程复杂，务必听从医生建议，绝不可自行更改剂量或方案。\u003C/li>\n        \u003Cli>主要药品注射剂型需在医院专业人员操作，口服药也要注意配合饮食和服药时间。\u003C/li>\n        \u003Cli>任何化疗药品都有明确剂量与禁忌，重要的不良反应需第一时间处理，安全性永远放首位。\u003C/li>\n        \u003Cli>用药中遇到疑问，应随时咨询主管医生或专业药师，不要因互联网信息自行盲目决策。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"bile-drug-p\">最后，再次强调整个化疗过程要关注三点：\u003Cstrong>规范操作、与医生密切沟通、按要求定期检查\u003C/strong>。妥善管理药品及安全用药，才能提升治疗效果并保障自身健康。\u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"bile-drug-section\" style=\"background: linear-gradient(90deg, #f5fdff 0%, #e3f5f5 100%); padding: 28px 20px 16px 20px;\">\n    \u003Ch3 class=\"bile-drug-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h3>\n    \u003Cul class=\"bile-drug-list-ref\">\n        \u003Cli>Levine, M. N., et al. (2021). Chemotherapy Principles and Safety. \u003Cem>Hematology/Oncology Clinics of North America\u003C/em>, 35(2), 247-260. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33611032/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n        \u003Cli>Baumann, F., et al. (2018). Management of Chemotherapy-Related Adverse Events. \u003Cem>Cancer Journal\u003C/em>, 24(2), 79-86. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29601109/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n        \u003Cli>Chalasani, P., and Coveler, A. L. (2020). Chemotherapy for gastrointestinal cancers. \u003Cem>Current Treatment Options in Oncology\u003C/em>, 21(6), 49. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32451766/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n        \u003Cli>Guerra, V. A., et al. (2020). Evaluation of Safety and Efficacy of Rituximab Infusion. \u003Cem>Journal of Oncology Pharmacy Practice\u003C/em>, 26(1), 48-54. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31758918/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n    \u003C/ul>\n\u003C/div>\n\n\u003Cstyle>\n.bile-drug-title {\n    font-size:32px;\n    font-weight:700;\n    color: #1c3f57;\n    margin-bottom:28px;\n    padding-top:22px;\n    letter-spacing:1px;\n}\n.bile-drug-section {\n    border-radius:14px;\n    box-shadow:0 3px 16px rgba(140,160,210,0.07);\n    margin-top:0;\n    margin-bottom:34px;\n}\n.bile-drug-h3 {\n    font-size:20px;\n    font-weight:600;\n    color:#244e66;\n    margin-bottom:12px;\n    padding-left:2px;\n}\n.bile-drug-emoji:before {\n    content:'';\n    display:inline-block;\n    margin-right:6px;\n}\n.bile-drug-list {\n    list-style:none;\n    margin:0 0 8px 0;\n    padding-left:0;\n}\n.bile-drug-list li {\n    position:relative;\n    font-size:16px;\n    color:#293a41;\n    margin-bottom:11px;\n    padding-left:20px;\n}\n.bile-drug-list li:before {\n    content:'✔️';\n    position:absolute;\n    left:0;\n    top:0px;\n    color:#6594c2;\n    font-size:15px;\n}\n.bile-drug-p {\n    font-size:16px;\n    color:#3d4977;\n    margin-bottom:12px;\n    margin-top:5px;\n    line-height:1.8;\n}\n.bile-drug-list-ref {\n    padding-left:0;\n    list-style:none;\n    font-size:15px;\n    color:#507587;\n}\n.bile-drug-list-ref li {\n    margin-bottom:10px;\n    padding-left:20px;\n    position:relative;\n}\n.bile-drug-list-ref li:before {\n    content:'📖';\n    position:absolute;\n    left:0;\n    color:#a8b5bb;\n}\na {\n    color:#176fa1;\n    text-decoration:underline;\n    font-size:15px;\n}\n\u003C/style>\n","\u003Ch2 id=\"material_title\" class=\"bile-drug-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6",438,"2025-09-04 11:23:46","胆管恶性肿瘤, 化疗药品, 安全用药, 药物相互作用, 不良反应","本文详解胆管恶性肿瘤化疗药品使用，提供清晰用药方案及安全注意事项，帮助患者和家属合理规避用药风险，优化治疗效果。","2025-09-08 14:03:13",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]